Pianowski
John C. Pianowski, South Lyon, MI US
Patent application number | Description | Published |
---|---|---|
20090200819 | Interior Trim Component and Method of Manufacturing the same - An interior trim component includes a body portion defining an inboard-surface, and an outboard-surface, wherein the body portion is further defined by a groove formed in the inboard-surface, and a passage extending through the body portion from the inboard-surface to the outboard-surface; and a bolster portion including a first end portion, and a second end portion, wherein the first end portion is disposed in the groove formed in the inboard-surface, wherein the second end portion is disposed in the passage. A method is also disclosed. | 08-13-2009 |
Luiz Pianowski, Braganca Paulista BR
Patent application number | Description | Published |
---|---|---|
20110144193 | Pharmaceutical Composition Comprising Cinchonains Ia And Ib, Process For Preparing An Epimeric Mixture Of Cinchonains Ia And Ib, Use And Method For Reverting/Combating Ventricular Fibrillation - The present invention relates to the effects of the epimeric mixture of cinchonains Ia and Ib on pathologies that involve alterations in the cardiovascular system, essentially in combating, preventing and reverting ventricular fibrillation in human beings and animals, especially for combating spontaneous or electric-stimulus-induced ventricular fibrillation, to revert spontaneous or electric-stimulus-induced ventricular fibrillations, for preventing ventricular fibrillation, for the treatment of ventricular fibrillation of any etiology or for the treatment of post-fibrillation to maintain normal cardiac rhythm. | 06-16-2011 |
20130217761 | Pharmaceutical Composition Comprising Cinchonains Ia and Ib, Process For Preparing An Epimeric Mixture of Cinchonains Ia and Ib, Use and Method for Reverting/Combating Ventricular Fibrillation - The present invention relates to the effects of the epimeric mixture of cinchonains Ia and Ib on pathologies that involve alterations in the cardiovascular system, in combating, preventing and reverting ventricular fibrillation in human beings and animals, especially for combating spontaneous or electric-stimulus-induced ventricular fibrillation, to revert spontaneous or electric-stimulus-induced ventricular fibrillations, for preventing ventricular fibrillation, for the treatment of ventricular fibrillation of any etiology or for the treatment of post-fibrillation to maintain normal cardiac rhythm. The present invention further relates to methods for the synthesis of an epimeric mixture of the chemical substances cinchonain Ia and Ib. The present invention also relates to the use of these chemical substances in reverting/combating ventricular fibrillation and/or in protecting against ventricular fibrillation. A pharmaceutical composition will be used for administering these chemical substances in human beings and animals. | 08-22-2013 |
Luiz F. Pianowski, Atibaia-Sp BR
Patent application number | Description | Published |
---|---|---|
20080280996 | Use of Carophyllenes in the Manufacture of Medicaments and Treatment of Bodily Conditions of Inflammation and Inflammatory Pain - The invention concerns the use of caryophyllenes related to medicaments and to the treatment of bodily conditions of inflammation and inflammatory pain. | 11-13-2008 |
Luiz F. Pianowski, Atibaia BR
Patent application number | Description | Published |
---|---|---|
20090142421 | ACTIVE FRACTION OF A POLAR SOLVENT EXTRACT FROM THE LATEX OF EUPHORBIACEAE PLANTS - The present invention generally refers to an active fraction of an extract of the latex of plants from the family Euphorbiaceae in a polar solvent, as well as of one or more compounds contained therein, as well as the use of said fraction and/or said compounds, particularly in the treatment of cancer. The invention also refers to compositions comprising said active fraction and/or said compounds, as well as their use for the treatment of diseases concerning cell proliferation/angiogenesis, particularly cancer. | 06-04-2009 |
Luiz Francisco Pianowski, Bragança Paulista-Sp BR
Patent application number | Description | Published |
---|---|---|
20120302593 | Use of at Least One Isoquinoline Compound of Formula I, Pharmaceutical Composition for Treating or Preventing Neurodegenerative Diseases and Method for Treating or Preventing Neurodegenerative Diseases - The present invention concern the use of isoquinoline alkaloid compounds of formula I in the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases, particularly Alzheimer's disease, as well as pharmaceutical composition comprising said compounds and method of treatment of neurodegenerative diseases | 11-29-2012 |
Luiz Francisco Pianowski, Bragança Paulista-Sp BR
Patent application number | Description | Published |
---|---|---|
20120302593 | Use of at Least One Isoquinoline Compound of Formula I, Pharmaceutical Composition for Treating or Preventing Neurodegenerative Diseases and Method for Treating or Preventing Neurodegenerative Diseases - The present invention concern the use of isoquinoline alkaloid compounds of formula I in the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases, particularly Alzheimer's disease, as well as pharmaceutical composition comprising said compounds and method of treatment of neurodegenerative diseases | 11-29-2012 |
Luiz Francisco Pianowski, Branganca Paulista BR
Patent application number | Description | Published |
---|---|---|
20150315124 | INGENOL-DERIVED COMPOUNDS THAT CAN BE USED FOR TREATING CANCER - The present invention relates to new ingenol derivative compounds for treating cancer. In other aspects, the invention relates to a pharmaceutical composition, medicament, method for treating cancer and dosage form. | 11-05-2015 |
Luiz Francisco Pianowski, Braganca Paulista BR
Patent application number | Description | Published |
---|---|---|
20120289487 | Pharmaceutical Use of Multicyclic Compounds as Anti-Aids Agents - This invention refers to pharmaceutical use of multicyclic compounds chosen from ingenols, lanosta-8,24-dien-3-ols and their mixtures, as anti-AIDS agents. | 11-15-2012 |
20140073655 | METHOD FOR TREATING FATIGUE - The present invention refers to an active moiety of | 03-13-2014 |
20140234234 | DEODORANT AND ANTIPERSPIRANT COMPOSITION, METHOD FOR PRODUCING A DEODORANT AND ANTIPERSPIRANT COMPOSITION, AND METHOD FOR PREVENTING AND/OR REDUCING PERSPIRATION ODOUR - The present invention relates to deodorant and antiperspirant compositions containing a natural active principle, containing tannins in the formulation. These compositions are suitable for use in all cosmetic formulations, such as sticks, aerosols, sprays and creams. The invention further relates to processes for production of deodorant and antiperspirant compositions, and to a method for prevention and/or reduction of perspiration odors. | 08-21-2014 |
20150030638 | Ingenol Derivatives in the Reactivation of Latent HIV - The present invention broadly relates to the use of certain ingenol derivatives as HIV reactivators of latent HIV virus in viral reservoirs. In another aspect, the present invention relates to an association comprising such ingenol derivatives and antiretroviral agents substantially active against actively replicating virus. | 01-29-2015 |
Luiz Francisco Pianowski, Mairiporá Sp BR
Patent application number | Description | Published |
---|---|---|
20110136773 | Pharmaceutical Uses of Lanosta-8,24-dien-3-ols - The invention generally refers to pharmaceutical uses of lanosta-8,24-dien-3-ols, a family of tetracyclic terpenols, as anti-inflammatory, anticancerigenous and analgesic agents via the inhibition of the disordered activation of serine-threonine protein kinases, particularly PKC. | 06-09-2011 |